Experts in the field of science and technology strive to bring innovative things to the forefront. The obsession with reaching the highest level of innovation has led to the development of revolutionary things.
Thanks to the hard work of this journey of almost half a century, today man has started the project of “Mortality Technology” of the artificial human brain. The human endeavor to promote science and technology through artificial intelligence. The term was coined by the scientist John McCarthy. He called it the science of making machines that have intelligence.
In the future, we will have machines that will not require humans to operate them. They will do all the work on their own. Similarly, vehicles with artificial intelligence will soon appear on the roads that drive themselves.
A few years ago, a technology firm called Nvidia developed a programming algorithm that processes the textures and impressions of about 70,000 human faces to present artificial portraits that look exactly like humans.
Experts say that artificial humans will be created who will be seen walking everywhere like living human beings in the future. But the only difference will be that these artificial human beings will not suffer from sleep, fatigue, illness, and death.
They will not be able to do everything that human beings are doing today, but they will also be able to do things that human beings cannot do today due to their limited mental capacity. Thanks to AI’s unique and unique techniques, the revolution in AI, especially in industries, computers, and robotics, is as clear as day. The real purpose of AI is to develop machines capable of thinking and understanding precisely like humans.
Simultaneously, machines need to be modernized so that they can understand the environment and react and perform tasks according to human desires in a matter of seconds, the most fantastic example of which is the creation of numerous robots.
Therefore, machines should be made capable of giving many times better results than human beings. The number of inventions that have emerged over the years is the lowest level of AI, as AI’s core program is to take technology to the point where the machine can perform tasks without human intervention. Numerous robots have been developed in this regard.
For example, a nurse robot, a surgical robot, a housewife, a caregiver for the elderly. The question is, for the next twenty years or less, scientists will be able to use the latest techniques.
They also manage to create an artificial brain by understanding how things work, and the machine can read human behavior, so will this be a new milestone for humanity or a catastrophe for us? Scientists should focus all their attention on creating intelligent systems that guarantee the well-being of society.
Still, on the contrary, our lives are becoming more and more entangled in the web of technology. The clash of humanity and technology seems to be imminent.
Oxford-based company Accentia, the first to use artificial intelligence to test a drug on humans, is researching 15,000 drugs at the Scar Eps Research Institute in California.
Viagra co-creator Dr. David Brown, The Cambridge-based Helix company, has turned to artificial intelligence systems to develop drugs for rare diseases. Now their goal is to find a cure for corona. But Dr. Brown says there is no way the disease can be cured with a single drug.
According to Professor Ara Darzi, director of the Institute of Global Health Innovation at Imperial College, artificial intelligence is one of the most important avenues we have to achieve a conceivable medicine. But the essential requirement for this is high quality and a set of big data.
To date, most of this information has been sent to individual companies such as large pharma companies or lost in old laboratories inside universities. More than ever, the data involved in the discovery of these nutritional drugs need to be gathered, so that artificial intelligence researchers can use their new machine learning techniques to discover coronary arteries as soon as possible.
Northeastern University’s Barabasi Laboratory in the United States, Harvard Medical School, the Stanford Network Science Institute, and biotech startup Schaefer Medicine are all looking for a drug that can be re-treated as soon as possible as a treatment for COVID-19.
Professor Albert Laszlo Barabasi says artificial intelligence can work much better, not only to improve order but also to look at independent information that may not be visible to network medicine.
But artificial intelligence can’t do it alone; it needs all three methods. Some artificial intelligence companies are already claiming that they have identified some drugs that can be helpful.
Human artificial intelligence has identified Benevolent as a possible treatment for the virus that infects lung cells, which can be used to treat osteoporosis (which causes inflammation in the water sacs in the joints). And now controlled trials are being conducted at the American Institute of Allergy and Infectious Diseases. Germany and the United Kingdom have also developed policies regarding artificial intelligence.